Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1 clinical trials · Condition
◉ Watch Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab (NCT05675410) | National Cancer Institute (NCI) | 2023-05-11 |
Track Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.